Trial Profile
Clinical study of chemoimmunotherapy with fresh frozen plasma, high dose methylprednisolone and rituximab for ultra-high risk CLL
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Apr 2016
Price :
$35
*
At a glance
- Drugs Methylprednisolone (Primary) ; Plasma (Primary) ; Rituximab (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 27 Aug 2012 New trial record